Kadant (KAI) will replace Inari Medical (NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19.
Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.95. According to InvestingPro analysis, the company, now valued at $4.69 billion, shows signs of being slightly ...
1. Stryker entered a definitive agreement to acquire medical device company Inari Medical for about $4.9 billion. 2. Stryker's net sales grew to $6.4 billion in the fourth quarter of 2024, and ...
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" ...
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s ...
In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other small-cap stocks. Wall Street is increasing its bet on small-cap stocks ...
Kadant Inc. (NYSE: KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp.